Moreover, the frequency of Ki67+PD-1+CD8+ T cells in the tumor microenvironment decreased significantly, which was reversed by anti-PD-L1 antibodies (Chen G. et al., 2018). This evidence concerns the gene PDCD1 and neoplasm.